Jens M. Chemnitz

3.9k total citations · 2 hit papers
18 papers, 3.0k citations indexed

About

Jens M. Chemnitz is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jens M. Chemnitz has authored 18 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in Jens M. Chemnitz's work include Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and T-cell and B-cell Immunology (4 papers). Jens M. Chemnitz is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and T-cell and B-cell Immunology (4 papers). Jens M. Chemnitz collaborates with scholars based in Germany and United States. Jens M. Chemnitz's co-authors include James L. Riley, Richard V. Parry, Inbal Braunstein, Anthony R. Lanfranco, Kim E. Nichols, Carl H. June, Kenneth A. Frauwirth, Sumire Kobayashi, Peter S. Linsley and Craig B. Thompson and has published in prestigious journals such as Blood, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Jens M. Chemnitz

18 papers receiving 3.0k citations

Hit Papers

CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Di... 2004 2026 2011 2018 2005 2004 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
    2005 1.5k citations Richard V. Parry, Jens M. Chemnitz et al. Molecular and Cellular Biology profile →
  2. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation
    2004 927 citations Jens M. Chemnitz, Richard V. Parry et al. The Journal of Immunology profile →

Peers

Jens M. Chemnitz
Gilles Thibault France
Jon M. Wigginton United States
Andrew J. Long United States
Michael Bowman United States
Yibei Zhu China
Katia Beider Israel
Kavita M. Dhodapkar United States
Periklis Foukas Greece
Ines Gütgemann Germany
Sigrid Dubois United States
Gilles Thibault France
Jens M. Chemnitz
Citations per year, relative to Jens M. Chemnitz Jens M. Chemnitz (= 1×) peers Gilles Thibault

Countries citing papers authored by Jens M. Chemnitz

Since Specialization
Citations

This map shows the geographic impact of Jens M. Chemnitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens M. Chemnitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens M. Chemnitz more than expected).

Fields of papers citing papers by Jens M. Chemnitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens M. Chemnitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens M. Chemnitz. The network helps show where Jens M. Chemnitz may publish in the future.

Co-authorship network of co-authors of Jens M. Chemnitz

This figure shows the co-authorship network connecting the top 25 collaborators of Jens M. Chemnitz. A scholar is included among the top collaborators of Jens M. Chemnitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens M. Chemnitz. Jens M. Chemnitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
3.
Holtick, Udo, Melanie Albrecht, Jens M. Chemnitz, et al.. (2014). Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 94(2). 179–188. 44 indexed citations
4.
Vehreschild, Jörg Janne, Maria J. G. T. Vehreschild, Dorothee Arenz, et al.. (2011). Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial. International Journal of Antimicrobial Agents. 39(2). 130–134. 16 indexed citations
5.
6.
Tresckow, Bastian von, Boris Böll, Dennis A. Eichenauer, et al.. (2011). A Phase II Clinical Trial of the Anti-EGFR Antibody Cetuximab in Patients with Refractory or Relapsed Multiple Myeloma: Final Results,. Blood. 118(21). 3965–3965. 2 indexed citations
7.
Chemnitz, Jens M., et al.. (2010). Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab. Annals of Hematology. 89(10). 1029–1033. 29 indexed citations
8.
Draube, Andreas, Jens M. Chemnitz, Claudia Wickenhauser, et al.. (2007). Cytomorphologic signs of severe pernicious anemia obscured in a patient with heterozygous hemoglobin Stanleyville II. European Journal Of Haematology. 79(4). 360–362. 2 indexed citations
9.
Claßen, Sabine, Thomas Zander, Daniela Eggle, et al.. (2007). Human Resting CD4+ T Cells Are Constitutively Inhibited by TGFβ under Steady-State Conditions. The Journal of Immunology. 178(11). 6931–6940. 32 indexed citations
10.
Chemnitz, Jens M., Daniela Eggle, Julia Driesen, et al.. (2007). RNA fingerprints provide direct evidence for the inhibitory role of TGFβ and PD-1 on CD4+ T cells in Hodgkin lymphoma. Blood. 110(9). 3226–3233. 66 indexed citations
11.
Chemnitz, Jens M., Julia Driesen, Sabine Claßen, et al.. (2006). Prostaglandin E2 Impairs CD4+ T Cell Activation by Inhibition of lck: Implications in Hodgkin's Lymphoma. Cancer Research. 66(2). 1114–1122. 84 indexed citations
12.
Chemnitz, Jens M., Anthony R. Lanfranco, Inbal Braunstein, & James L. Riley. (2006). B and T Lymphocyte Attenuator-Mediated Signal Transduction Provides a Potent Inhibitory Signal to Primary Human CD4 T Cells That Can Be Initiated by Multiple Phosphotyrosine Motifs. The Journal of Immunology. 176(11). 6603–6614. 67 indexed citations
13.
Parry, Richard V., Jens M. Chemnitz, Kenneth A. Frauwirth, et al.. (2005). CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms. Molecular and Cellular Biology. 25(21). 9543–9553. 1541 indexed citations breakdown →
14.
Chemnitz, Jens M., Richard V. Parry, Kim E. Nichols, Carl H. June, & James L. Riley. (2004). SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology. 173(2). 945–954. 927 indexed citations breakdown →
15.
Chemnitz, Jens M., James L. Riley, Kenneth A. Frauwirth, et al.. (2004). CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms.. Blood. 104(11). 2657–2657. 42 indexed citations
16.
Chemnitz, Jens M., Andreas Draube, Christof Scheid, et al.. (2002). Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab. American Journal of Hematology. 71(2). 105–108. 94 indexed citations
17.
Chemnitz, Jens M., Andreas Draube, Volker Diehl, & Jürgen Wolf. (2002). Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab. American Journal of Hematology. 69(3). 232–232. 1 indexed citations
18.
Chemnitz, Jens M., et al.. (2001). Thrombotisch-thrombozytopenische Purpura (Moschcowitz-Syndrom). Medizinische Klinik. 96(6). 343–350. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gilles Thibault Breakdown of academic impact, for papers by Jon M. Wigginton Breakdown of academic impact, for papers by Andrew J. Long Breakdown of academic impact, for papers by Michael Bowman Breakdown of academic impact, for papers by Yibei Zhu Breakdown of academic impact, for papers by Katia Beider Breakdown of academic impact, for papers by Kavita M. Dhodapkar Breakdown of academic impact, for papers by Periklis Foukas Breakdown of academic impact, for papers by Ines Gütgemann Breakdown of academic impact, for papers by Sigrid Dubois
Rankless by CCL
2026